• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定出严重急性呼吸综合征冠状病毒(SARS-CoV)刺突蛋白(S蛋白)中一个对病毒进入至关重要的新区域。

Identification of a new region of SARS-CoV S protein critical for viral entry.

作者信息

Guo Ying, Tisoncik Jennifer, McReynolds Susanna, Farzan Michael, Prabhakar Bellur S, Gallagher Thomas, Rong Lijun, Caffrey Michael

机构信息

Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.

出版信息

J Mol Biol. 2009 Dec 11;394(4):600-5. doi: 10.1016/j.jmb.2009.10.032. Epub 2009 Oct 21.

DOI:10.1016/j.jmb.2009.10.032
PMID:19853613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2794126/
Abstract

Infection by severe acute respiratory syndrome coronavirus (SARS-CoV) is initiated by specific interactions between the SARS-CoV spike (S) protein and its receptor ACE2. In this report, we screened a peptide library representing the SARS-CoV S protein sequence using a human immunodeficiency virus-based pseudotyping system to identify specific regions that affect viral entry. One of the 169 peptides screened, peptide 9626 (S residues 217-234), inhibited SARS-CoV S-mediated entry of the pseudotyped virions in 293T cells expressing a functional SARS-CoV receptor (human angiotensin-converting enzyme 2) in a dose-dependent manner (IC(50) approximately 11 microM). Alanine scanning mutagenesis was performed to assess the roles of individual residues within this region of S, which was previously uncharacterized. The effects included significant reductions in expression (K223A), viral incorporation (L218A, I230A, and N232A), and reduced viral entry (L224A, L226A, I228A, T231A, and F233A). Taken together, these results reveal a new region of the S protein that is crucial for SARS-CoV entry.

摘要

严重急性呼吸综合征冠状病毒(SARS-CoV)的感染是由SARS-CoV刺突(S)蛋白与其受体血管紧张素转换酶2(ACE2)之间的特异性相互作用引发的。在本报告中,我们使用基于人类免疫缺陷病毒的假型系统筛选了一个代表SARS-CoV S蛋白序列的肽库,以鉴定影响病毒进入的特定区域。在筛选的169种肽中,肽9626(S蛋白第217 - 234位氨基酸残基)以剂量依赖性方式抑制了SARS-CoV S介导的假型病毒粒子进入表达功能性SARS-CoV受体(人类血管紧张素转换酶2)的293T细胞(半数抑制浓度约为11微摩尔)。进行丙氨酸扫描诱变以评估S蛋白这一此前未被表征区域内各个残基的作用。这些作用包括表达显著降低(K223A)、病毒掺入减少(L218A、I230A和N232A)以及病毒进入减少(L224A、L226A、I228A、T231A和F233A)。综上所述,这些结果揭示了S蛋白中一个对SARS-CoV进入至关重要的新区域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/ac7a176eb412/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/d2667a5ff8bc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/56933eb91861/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/f47bfeecc03d/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/ac7a176eb412/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/d2667a5ff8bc/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/56933eb91861/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/f47bfeecc03d/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f692/7094729/ac7a176eb412/gr4_lrg.jpg

相似文献

1
Identification of a new region of SARS-CoV S protein critical for viral entry.鉴定出严重急性呼吸综合征冠状病毒(SARS-CoV)刺突蛋白(S蛋白)中一个对病毒进入至关重要的新区域。
J Mol Biol. 2009 Dec 11;394(4):600-5. doi: 10.1016/j.jmb.2009.10.032. Epub 2009 Oct 21.
2
Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry.不同蝙蝠物种的血管紧张素转换酶 2(ACE2)蛋白对 SARS-CoV 进入具有不同的易感性。
Arch Virol. 2010 Oct;155(10):1563-9. doi: 10.1007/s00705-010-0729-6. Epub 2010 Jun 22.
3
Angiotensin-converting enzyme 2 (ACE2) from raccoon dog can serve as an efficient receptor for the spike protein of severe acute respiratory syndrome coronavirus.貉的血管紧张素转换酶2(ACE2)可作为严重急性呼吸综合征冠状病毒刺突蛋白的有效受体。
J Gen Virol. 2009 Nov;90(Pt 11):2695-2703. doi: 10.1099/vir.0.013490-0. Epub 2009 Jul 22.
4
Retroviruses pseudotyped with the severe acute respiratory syndrome coronavirus spike protein efficiently infect cells expressing angiotensin-converting enzyme 2.用严重急性呼吸综合征冠状病毒刺突蛋白假型化的逆转录病毒能有效感染表达血管紧张素转换酶2的细胞。
J Virol. 2004 Oct;78(19):10628-35. doi: 10.1128/JVI.78.19.10628-10635.2004.
5
A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2.SARS 冠状病毒刺突蛋白受体结合域的六肽通过人受体 ACE2 阻断病毒进入宿主细胞。
Antiviral Res. 2012 Jun;94(3):288-96. doi: 10.1016/j.antiviral.2011.12.012. Epub 2012 Jan 17.
6
Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor.鉴定严重急性呼吸综合征冠状病毒(SARS-CoV)进入细胞过程中血管紧张素转换酶2(ACE2)上的关键决定因素并开发一种有效的进入抑制剂。
Virology. 2006 Jun 20;350(1):15-25. doi: 10.1016/j.virol.2006.01.029. Epub 2006 Feb 28.
7
Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry.严重急性呼吸综合征冠状病毒(SARS-CoV)的刺突蛋白和血管紧张素转换酶2(ACE2)对肿瘤坏死因子-α转换酶的调节可诱导肿瘤坏死因子-α的产生并促进病毒进入。
Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7809-14. doi: 10.1073/pnas.0711241105. Epub 2008 May 19.
8
The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization.严重急性呼吸综合征冠状病毒S糖蛋白受体结合结构域:精细定位与功能特性分析
Virol J. 2005 Aug 25;2:73. doi: 10.1186/1743-422X-2-73.
9
Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2.严重急性呼吸综合征冠状病毒刺突蛋白受体结合域与病毒受体血管紧张素转换酶2的内吞作用。
Virus Res. 2008 Sep;136(1-2):8-15. doi: 10.1016/j.virusres.2008.03.004. Epub 2008 Jun 12.
10
TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds.TACE 拮抗剂阻断了由 SARS-CoV 刺突蛋白引起的 ACE2 脱落,是候选的抗病毒化合物。
Antiviral Res. 2010 Mar;85(3):551-5. doi: 10.1016/j.antiviral.2009.12.001. Epub 2009 Dec 6.

引用本文的文献

1
Binding Affinity Measurements Between DNA Aptamers and their Virus Targets Using ELONA and MST.使用酶联寡核苷酸吸附测定法(ELONA)和微量热泳动法(MST)测量DNA适配体与其病毒靶点之间的结合亲和力
Bio Protoc. 2022 Nov 5;12(21). doi: 10.21769/BioProtoc.4548.
2
Overcoming the limitations of COVID-19 diagnostics with nanostructures, nucleic acid engineering, and additive manufacturing.利用纳米结构、核酸工程和增材制造克服新冠病毒诊断的局限性。
Curr Opin Solid State Mater Sci. 2022 Feb;26(1):100966. doi: 10.1016/j.cossms.2021.100966. Epub 2021 Nov 20.
3
Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors.

本文引用的文献

1
Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites.通过在两个不同位点进行顺序蛋白水解切割来激活严重急性呼吸综合征冠状病毒刺突蛋白。
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6. doi: 10.1073/pnas.0809524106. Epub 2009 Mar 24.
2
HIV entry inhibitors and their potential in HIV therapy.HIV进入抑制剂及其在HIV治疗中的潜力。
Med Res Rev. 2009 Mar;29(2):369-93. doi: 10.1002/med.20138.
3
Characterization of the prefusion and transition states of severe acute respiratory syndrome coronavirus S2-HR2.
利用DNA适配体-纳米孔传感器直接检测人腺病毒或SARS-CoV-2并具备告知感染性的能力。
Sci Adv. 2021 Sep 24;7(39):eabh2848. doi: 10.1126/sciadv.abh2848. Epub 2021 Sep 22.
4
Exploring peptide studies related to SARS-CoV to accelerate the development of novel therapeutic and prophylactic solutions against COVID-19.探索与 SARS-CoV 相关的肽研究,以加速针对 COVID-19 的新型治疗和预防解决方案的开发。
J Infect Public Health. 2021 Aug;14(8):1106-1119. doi: 10.1016/j.jiph.2021.06.017. Epub 2021 Jul 3.
5
Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option.关于当前新冠病毒治疗方法以及将针对严重急性呼吸综合征冠状病毒1(SARS-CoV-1)的候选药物重新用于靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)作为快速治疗和预防选择的潜力的综合综述。
Ann Transl Med. 2020 Oct;8(19):1247. doi: 10.21037/atm-20-4071.
6
Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD.中东呼吸综合征冠状病毒 S1-NTD 上中和敏感性表位的结构定义。
Cell Rep. 2019 Sep 24;28(13):3395-3405.e6. doi: 10.1016/j.celrep.2019.08.052.
7
A self-adjuvanted nanoparticle based vaccine against infectious bronchitis virus.一种基于自佐剂纳米颗粒的传染性支气管炎病毒疫苗。
PLoS One. 2018 Sep 14;13(9):e0203771. doi: 10.1371/journal.pone.0203771. eCollection 2018.
8
The S2 Subunit of Infectious Bronchitis Virus Beaudette Is a Determinant of Cellular Tropism.传染性支气管炎病毒 Beaudette S2 亚基是决定细胞嗜性的因素。
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.01044-18. Print 2018 Oct 1.
9
Establishment of pseudovirus infection mouse models for pharmacodynamics evaluation of filovirus entry inhibitors.用于丝状病毒进入抑制剂药效学评价的假病毒感染小鼠模型的建立。
Acta Pharm Sin B. 2018 Mar;8(2):200-208. doi: 10.1016/j.apsb.2017.08.003. Epub 2017 Sep 22.
10
Probing the metastable state of influenza hemagglutinin.探测流感血凝素的亚稳态。
J Biol Chem. 2017 Dec 29;292(52):21590-21597. doi: 10.1074/jbc.M117.815043. Epub 2017 Nov 10.
严重急性呼吸综合征冠状病毒S2-HR2的融合前和过渡态的表征
Biochemistry. 2008 Jul 1;47(26):6802-8. doi: 10.1021/bi800622t. Epub 2008 Jun 10.
4
Structures and polymorphic interactions of two heptad-repeat regions of the SARS virus S2 protein.严重急性呼吸综合征病毒S2蛋白两个七肽重复区域的结构及多态性相互作用
Structure. 2006 May;14(5):889-99. doi: 10.1016/j.str.2006.03.007.
5
Solution structure of the severe acute respiratory syndrome-coronavirus heptad repeat 2 domain in the prefusion state.严重急性呼吸综合征冠状病毒融合前状态下七肽重复序列2结构域的溶液结构
J Biol Chem. 2006 Apr 28;281(17):11965-71. doi: 10.1074/jbc.M601174200. Epub 2006 Feb 28.
6
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.严重急性呼吸综合征冠状病毒,而非人冠状病毒NL63,利用组织蛋白酶L感染表达血管紧张素转换酶2的细胞。
J Biol Chem. 2006 Feb 10;281(6):3198-203. doi: 10.1074/jbc.M508381200. Epub 2005 Dec 8.
7
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.与受体复合的严重急性呼吸综合征冠状病毒刺突受体结合结构域的结构
Science. 2005 Sep 16;309(5742):1864-8. doi: 10.1126/science.1116480.
8
Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants.通过动物研究、表位作图及刺突变异体分析评估人单克隆抗体80R对严重急性呼吸综合征的免疫预防作用。
J Virol. 2005 May;79(10):5900-6. doi: 10.1128/JVI.79.10.5900-5906.2005.
9
Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: implications for the viral fusion mechanism.使用16/18聚体肽扫描鉴定严重急性呼吸综合征冠状病毒刺突膜糖蛋白的膜活性区域:对病毒融合机制的启示
J Virol. 2005 Feb;79(3):1743-52. doi: 10.1128/JVI.79.3.1743-1752.2005.
10
CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus.CD209L(L-选择素)是严重急性呼吸综合征冠状病毒的一种受体。
Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15748-53. doi: 10.1073/pnas.0403812101. Epub 2004 Oct 20.